EP0584212A4 - Vaccins comprenant un polysaccharide encapsule dans un liposome. - Google Patents

Vaccins comprenant un polysaccharide encapsule dans un liposome.

Info

Publication number: EP0584212A4
Authority: EP; European Patent Office
Prior art keywords: polysaccharid; liposomal; vaccine; polysaccharid vaccine; liposomal polysaccharid
Prior art date: 1991-05-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP19920911814

Other languages

German (de)

English (en)

Other versions

EP0584212A1 (fr

Inventor

Edward Abraham

Yi-Han Chang

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of California Berkeley

University of California San Diego UCSD

Original Assignee

University of California Berkeley

University of California San Diego UCSD

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-13

Filing date

1992-05-13

Publication date

1994-11-30

1992-05-13 Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley

1994-03-02 Publication of EP0584212A1 publication Critical patent/EP0584212A1/fr

1994-11-30 Publication of EP0584212A4 publication Critical patent/EP0584212A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/104—Pseudomonadales, e.g. Pseudomonas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Microbiology (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Dispersion Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

EP19920911814 1991-05-13 1992-05-13 Vaccins comprenant un polysaccharide encapsule dans un liposome. Withdrawn EP0584212A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US69914491A	1991-05-13	1991-05-13
US699144		1991-05-13

Publications (2)

Publication Number	Publication Date
EP0584212A1 EP0584212A1 (fr)	1994-03-02
EP0584212A4 true EP0584212A4 (fr)	1994-11-30

Family

ID=24808131

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP19920911814 Withdrawn EP0584212A4 (fr)	1991-05-13	1992-05-13	Vaccins comprenant un polysaccharide encapsule dans un liposome.

Country Status (8)

Country	Link
EP (1)	EP0584212A4 (fr)
JP (1)	JPH07500813A (fr)
AU (1)	AU665762B2 (fr)
CA (1)	CA2109316A1 (fr)
FI (1)	FI934866L (fr)
HU (1)	HUT67159A (fr)
NO (1)	NO934106L (fr)
WO (1)	WO1992020370A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0708656B1 (fr) *	1993-04-27	2002-07-31	United Biomedical, Inc.	Peptides immunogenes de la lhrh et stimulators d'immunite universelle de synthese pour vaccins
FR2716373B1 (fr) *	1994-02-23	1996-05-03	Pasteur Institut	Liposomes, et leur utilisation pour l'obtention de vaccins.
WO1998040062A1 (fr) *	1997-03-11	1998-09-17	Stichting Dienst Landbouwkundig Onderzoek	Utilisation de liposomes contenant un agent chelateur, un fongicide ou un secropine pour ameliorer la vaccination muqueuse
US6749831B1 (en)	1997-05-16	2004-06-15	Medical Defense Technology, Llc	Vaccine against lipopolysaccharide core
US7534442B2 (en)	2001-08-21	2009-05-19	The Brigham And Women's Hospital, Inc.	Immunogenic compositions comprising covalently bound polysaccharides, antigen, and bacterial toxoid
EP1928418B1 (fr)	2005-09-30	2011-12-21	Lipoxen Technologies Limited	Compositions vaccinales liposomales comprenant un antigene polysaccharide et un adjuvant proteique
GB2548848A (en) *	2016-03-30	2017-10-04	The Inst Of Food Res	Levan polysaccharide to modulate cell function

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0017557A2 (fr) *	1979-03-26	1980-10-15	Merck & Co. Inc.	Particule de liposome contenant des sous-unités virales ou bactériennes antigéniques et procédé de préparation
WO1991001143A1 (fr) *	1989-07-14	1991-02-07	Praxis Biologics, Inc.	Compositions de vaccin stable contenant des interleukines

1992
- 1992-05-13 FI FI934866A patent/FI934866L/fi not_active Application Discontinuation
- 1992-05-13 EP EP19920911814 patent/EP0584212A4/fr not_active Withdrawn
- 1992-05-13 WO PCT/US1992/004055 patent/WO1992020370A1/fr not_active Ceased
- 1992-05-13 JP JP4511002A patent/JPH07500813A/ja active Pending
- 1992-05-13 HU HU9303207A patent/HUT67159A/hu unknown
- 1992-05-13 AU AU19029/92A patent/AU665762B2/en not_active Ceased
- 1992-05-13 CA CA002109316A patent/CA2109316A1/fr not_active Abandoned
1993
- 1993-11-12 NO NO934106A patent/NO934106L/no unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0017557A2 (fr) *	1979-03-26	1980-10-15	Merck & Co. Inc.	Particule de liposome contenant des sous-unités virales ou bactériennes antigéniques et procédé de préparation
WO1991001143A1 (fr) *	1989-07-14	1991-02-07	Praxis Biologics, Inc.	Compositions de vaccin stable contenant des interleukines

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ABRAHAM I. ET AL.: "Oral immunization with bacterial polysaccharide and adjuvant enhances antigen-specific pulmonary secretory antibody response and resistance to pneumonia", VACCINE, vol. 9, no. 10, October 1991 (1991-10-01), GUILDFORD GB, pages 757 - 764 *
MBAWUIKE I.N. ET AL.: "Enhancement of the protective efficacity of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes", VACCINE, vol. 8, no. 4, August 1990 (1990-08-01), GUILDFORD GB, pages 347 - 352 *
See also references of WO9220370A1 *

Also Published As

Publication number	Publication date
NO934106L (no)	1994-01-12
WO1992020370A1 (fr)	1992-11-26
NO934106D0 (no)	1993-11-12
HU9303207D0 (en)	1994-03-28
FI934866A7 (fi)	1993-11-12
FI934866L (fi)	1993-11-12
AU1902992A (en)	1992-12-30
HUT67159A (en)	1995-02-28
CA2109316A1 (fr)	1992-11-14
FI934866A0 (fi)	1993-11-03
AU665762B2 (en)	1996-01-18
JPH07500813A (ja)	1995-01-26
EP0584212A1 (fr)	1994-03-02

Publication	Publication Date	Title
FI922958A0 (fi)	1992-06-25	Farmaceutisk sammansaettning.
FI921060A0 (fi)	1992-03-11	Farmaceutiska aerosolformuleringar.
FI922316A0 (fi)	1992-05-21	Farmaceutisk sammansaettning.
FI922252A0 (fi)	1992-05-18	Farmaceutisk sammansaettning.
DE122006000020I1 (de)	2011-12-01	Aerosolpraparate.
DE69206353D1 (de)	1996-01-11	Anlasser.
FI923581A0 (fi)	1992-08-11	Farmaceutisk kombinationsformation.
FI923753A0 (fi)	1992-08-20	Vatten-i-olja-polymeremulsioner.
FR2676925B1 (fr)	1995-05-12	Liposomes.
FI911308L (fi)	1991-09-20	Lipopeptidderivat.
FI923238A0 (fi)	1992-07-15	Cysteinamid innehaollande permanent.
FI924058A0 (fi)	1992-09-10	Membranavbrytare.
EP0584212A4 (fr)	1994-11-30	Vaccins comprenant un polysaccharide encapsule dans un liposome.
ES1016723Y (es)	1992-08-01	Boligrafo-pulverizador mejorado.
FI924241A0 (fi)	1992-09-22	Temperaturkompenseringskrets foer en induktiv motor.
FI921785A0 (fi)	1992-04-22	Farmaceutisk foerening.
FI921786A0 (fi)	1992-04-22	Farmaceutisk foerening.
DE59105384D1 (de)	1995-06-08	Anomaloskop.
FI910079A0 (fi)	1991-01-07	Gaongjaern.
ID1028B (id)	1996-10-22	Vaksin
NO911473D0 (no)	1991-04-15	Motor.
NO911475D0 (no)	1991-04-16	Krykker.
ES1017003Y (es)	1992-06-01	Carpa.
ES1017618Y (es)	1992-07-16	Flexometro-trazador.
ES1016842Y (es)	1992-06-01	Carpeta-agenda.

Legal Events

Date	Code	Title	Description
1994-01-14	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1994-03-02	17P	Request for examination filed	Effective date: 19931213
1994-03-02	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
1994-11-30	A4	Supplementary search report drawn up and despatched	Effective date: 19941013
1994-11-30	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU MC NL SE
1997-11-12	17Q	First examination report despatched	Effective date: 19970924
1998-07-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
1998-08-19	18D	Application deemed to be withdrawn	Effective date: 19980205